Biofil Chemicals

BIOFILCHEM03 May 2024

Pharmaceuticals

₹

-1.99 (-2.87%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Biofil Chemicals

Biofil Chemicals

Pharmaceuticals

BIOFILCHEM03 May 2024

₹

-1.99 (-2.87%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
29-Mar-2024	BC	Continuous Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 for completion of tenure of second and final term of Smt. Shaila Jain (DIN: 00326130), as an Independent Director of the Com	31-Mar-2024
06-Feb-2024	BC	With reference to the above captioned subject, we would like to inform you that Board of Directors of the Company in their meeting (Serial No. 04/2023-2024) held today i.e., Tuesday, 06th day of Febr	15-Mar-2024
12-Mar-2024	BC	Manali Simon	11-Mar-2024
12-Mar-2024	BC	Sandeep Shah	11-Mar-2024
30-Jan-2024	BC	BIOFIL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 inter alia to consider and approve un-audited Financial Re	06-Feb-2024

No Rights has been declared by BIOFILCHEM

Book Closure

Record Date	Split Date	Purpose
31-Mar-2024	-	Continuous Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 for completion of tenure of second and final term of Smt. Shaila Jain (DIN: 00326130), as an Independent Director of the Com
15-Mar-2024	01 Jan'1900	With reference to the above captioned subject, we would like to inform you that Board of Directors of the Company in their meeting (Serial No. 04/2023-2024) held today i.e., Tuesday, 06th day of Febr
11-Mar-2024	-	Manali Simon
11-Mar-2024	-	Sandeep Shah
06-Feb-2024	-	BIOFIL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 inter alia to consider and approve un-audited Financial Re

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Biofil Chemicals & Pharmaceuticals Ltd ₹67.29(-1.99/-2.87%)	67.29	-1.99	112.72	54.06	168.98	6.38
Astrazeneca Pharma India Ltd ₹5,378.45(+44.60/0.84%)	5,378.45	+44.60	13,334.63	67.79	83.60	20.36
Bliss GVS Pharma Ltd ₹120.75(-8.45/-6.54%)	120.75	-8.45	1,352.61	67.42	19.82	1.38
Cipla Ltd ₹1,421.85(+2.30/0.16%)	1,421.85	+2.30	114,613.75	54.95	34.85	4.43
Amrutanjan Health Care Ltd ₹772.00(-14.60/-1.86%)	772.00	-14.60	2,274.11	29.81	51.68	8.68
Abbott India Ltd ₹26,141.45(-462.90/-1.74%)	26,141.45	-462.90	56,534.24	18.89	49.35	18.18

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	5.03	17.37	2.43	13.62	1.49	2.62
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	5.03	17.37	2.43	13.62	1.49	2.62
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.03	0.03	0.02	0.03	0.02	0.02
Total Income	5.06	17.40	2.46	13.65	1.52	2.64
Total Expenditure	4.84	17.13	2.02	13.21	1.27	2.46
PBIDT	0.22	0.27	0.44	0.44	0.25	0.18
Interest	0.00	0.01	0.01	0.01	0.01	0.01
PBDT	0.22	0.26	0.43	0.43	0.24	0.17
Depreciation	0.11	0.11	0.11	0.11	0.11	0.11
Tax	0.02	0.03	0.08	0.11	0.03	0.02
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	0.09	0.12	0.24	0.21	0.10	0.05
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.09	0.12	0.24	0.21	0.10	0.05

EPS (Unit Curr.)	0.06	0.08	0.15	0.07	0.06	0.03
EPS (Adj) (Unit Curr.)	0.06	0.08	0.15	0.07	0.06	0.03
Calculated EPS (Unit Curr.)	0.06	0.08	0.15	0.13	0.06	0.03
Calculated EPS (Adj) (Unit Curr.)	0.06	0.08	0.15	0.13	0.06	0.03
Calculated EPS (Ann.) (Unit Curr.)	0.23	0.30	0.60	0.51	0.25	0.11
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.23	0.30	0.60	0.51	0.25	0.11
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	16.27	16.27	16.27	16.27	16.27	16.27
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	4.37	1.55	18.11	3.23	16.78	6.87
PBDTM(%)	4.37	1.50	17.70	3.16	16.11	6.49
PATM(%)	1.79	0.69	9.88	1.54	6.71	1.91

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	16.27	16.27	16.27	16.27	16.27	16.27
Reserves Total	1.03	0.56	-0.14	-1.39	-2.62	-3.11
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	17.30	16.83	16.13	14.88	13.65	13.16
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	0.53	0.46	0.43	1.19	1.64	1.56
Total Debt	0.53	0.46	0.43	1.19	1.64	1.56
Total Liabilities	17.83	17.29	16.56	16.07	15.29	14.72
APPLICATION OF FUNDS :
Gross Block	11.63	11.62	11.55	11.45	11.24	9.83
Less : Accumulated Depreciation	2.63	2.20	1.77	1.36	0.95	0.59
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	9.00	9.42	9.78	10.09	10.29	9.24
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	1.21	1.29	4.34	1.69	1.19	1.02
Sundry Debtors	20.50	7.17	17.22	29.71	12.03	12.98
Cash and Bank	0.04	0.14	0.44	0.26	0.14	0.37
Loans and Advances	0.65	0.70	1.46	0.62	0.57	0.53
Total Current Assets	22.41	9.31	23.47	32.27	13.92	14.91
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	12.97	0.76	16.00	26.04	8.81	9.32
Provisions	0.23	0.27	0.33	0.25	0.12	0.11
Total Current Liabilities	13.20	1.03	16.32	26.29	8.93	9.43
Net Current Assets	9.21	8.28	7.14	5.98	4.99	5.48
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.03	0.02	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.41	0.42	0.36	0.00	0.00	0.00
Net Deferred Tax	-0.38	-0.40	-0.36	0.00	0.00	0.00
Total Assets	17.83	17.30	16.56	16.07	15.28	14.73
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.14	0.44	0.26	0.14	0.37
Net Cash from Operating Activities	-0.11	-0.22	1.11	0.89	1.26
Net Cash Used In Investing Activities	-0.01	-0.07	-0.10	-0.21	-1.41
Net Cash Used In Financing Activities	0.02	-0.01	-0.83	-0.57	-0.08
Net Inc./Dec In Cash And Cash Equivalents	-0.11	-0.30	0.18	0.12	-0.24
Cash And Cash Equivalents At End Of The Year	0.04	0.14	0.44	0.26	0.14

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

46.82%

FII Shareholding

0.03%

DII Shareholding

0.08%

Public Shareholding

53.08%

**Promoter pledged shareholding 46.82%

About Biofil Chemicals & Pharmaceuticals Ltd

Biofil Chemicals & Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 112.72 crores. It has reported a sales of Rs. 5.03 crores and a net profit of Rs. 0.09 crores for the quarter ended December 2018. The company management includes Ramesh Shah, Ramesh Shah,Romil Shah,Shaila Jain,Satish Beohar,Ashok Kumar Ramawat,Ketan Shah,Shweta Verma,Gayatri Padiyar (Biofil Chemicals & Pharmaceuticals Ltd) among others.

Chairman

Ramesh Shah

Registered office

11/12 Sector E Sanwer Road,Sanwer Road Industrial Area,Indore,Madhya Pradesh,452015

FAX :91-731-2420926

Background

Incorporation Year1985

Face Value₹10

Market Lot1

How to buy Biofil Chemicals shares on nse?

To buy Biofil Chemicals shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Biofil Chemicals share price today?

The Biofil Chemicals shares price on nse is Rs.67.29 today.

What is the market cap of Biofil Chemicals shares on BSE ?

The company has a market capitalization of Rs.112.72Cr

What is the PE & PB ratio of Biofil Chemicals shares ?

PE is 168.98 and PB is 6.38

What is the 52 Week High and Low of Biofil Chemicals shares?

Biofil Chemicals stock price high: Rs.78.8 Biofil Chemicals stock price low: Rs.41.01